泌尿道感染治疗市场基于(主要区域、市场参与者、规模和每一个)- 预测至 2031 年

  • Report Code : TIPRE00005931
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

泌尿道感染治疗市场规模预计将从 2023 年的 101 亿美元增至 2031 年的 130.2 亿美元。预计 2022-2031 年市场复合年增长率为 3.2%。开发新型替代疗法(例如 UTI 营养补充剂)可能仍是泌尿道感染治疗市场的主要趋势。

 

泌尿道感染治疗市场分析

尿路感染 (UTI) 是指细菌(主要来自皮肤或直肠)进入尿道并感染尿道。虽然尿道的多个部位都可能受到影响,但最常见的 UTI 类型是膀胱感染(膀胱炎)。另一方面,肾脏感染(肾盂肾炎)不太常见,但比膀胱感染更严重。UTI 的患病率不断上升,增加了对其预防和治疗疗法(如抗生素)的需求。

 

泌尿道感染治疗市场概况

远程患者监测和人工智能等分子诊断技术的进步有望提高诊断程序的效率。大多数行业参与者专注于开发和推出先进的试剂盒和设备,旨在改进家庭诊断过程。例如,2024 年 2 月,PathogenDx 推出了其 D3 Array-UTI 测试。该测试是一种多重 PCR 测试,能够检测 26 种不同的病原体和 12 种抗生素耐药基因标记。测试结果可以帮助临床医生快速治疗 UTI。此外,老年人口的增加预计将在未来十年带来对 UTI 治疗的需求。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

泌尿道感染治疗市场:

泌尿道感染治疗市场

  • 复合年增长率(2023 - 2031)
    3.2%
  • 2023 年市场规模
    101 亿美元
  • 2031年市场规模
    130.2亿美元

市场动态

增长动力
  • 泌尿道感染患病率不断上升以及分子诊断技术的进步
未来的趋势
  • 增加研发活动
机会
  • 开发新型替代疗法,如尿路感染营养补充剂

关键人物;主力;重要一员

  • 阿尔米拉尔公司
  • 雷迪斯博士实验室有限公司
  • 艾尔建
  • 葛兰素史克公司
  • 盐野义制药株式会社
  • 诺华公司
  • 辉瑞
  • 默克公司
  • 百时美施贵宝公司
  • 再生元制药

区域概况

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

药物类别
  • 青霉素及联合用药
  • 喹诺酮类
  • 头孢菌素
  • 氨基糖苷类抗生素
  • 磺胺类药物
  • 营养补充剂
指征
  • 复杂性尿路感染和非复杂性尿路感染
分销渠道
  • 医院药房
  • 妇科及泌尿科诊所
  • 零售药店和药店
  • 网上药店
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

泌尿道感染治疗市场驱动因素和机遇

 

泌尿道感染病例不断增加,利好市场

UTI 患病率的上升是推动泌尿道感染治疗市场增长的主要因素之一。例如,根据美国医师学会和美国传染病学会的一组研究人员在 2020 年进行的一项研究,UTI 每年在美国约占 600 万次就诊人数。UTI 发病率的上升是全球泌尿道感染治疗市场份额的主要驱动力。

 

增加研发活动——UTI治疗的机遇

泌尿道感染治疗领域的研发有望为全球泌尿道感染治疗市场参与者提供丰厚的增长机会。此外,2020 年 2 月,由 Venatorx Pharmaceuticals 和全球抗生素研究与开发伙伴关系 (GARDP) 开发的一种用于治疗泌尿道和细菌感染的新型抗生素疗法正在接受 FDA 的最终审查。该疗法代表了治疗复杂性泌尿道感染和高耐药性细菌引起的严重感染的重大进展。

 

泌尿道感染治疗市场报告细分分析

有助于得出泌尿道感染治疗市场分析的关键部分是药物类别、适应症和分销渠道。

  • 根据药物类别,市场细分为青霉素及其组合、喹诺酮类、头孢菌素、氨基糖苷类抗生素、磺胺类和营养补充剂。喹诺酮类药物在 2023 年占据了最大的市场份额。
  • 根据适应症,市场分为复杂性尿路感染和非复杂性尿路感染。复杂性尿路感染部分在 2023 年占据了最大的市场份额。
  • 就分销渠道而言,市场细分为医院药房、妇科和泌尿科诊所、零售药房和药店、网上药店。医院药房部门在 2023 年占据了市场主导地位。

 

泌尿道感染治疗市场份额按地区分析

泌尿道感染治疗市场报告的地理范围主要分为五个区域:北美、亚太、欧洲、中东和非洲、南美和中美。

北美主导着泌尿道感染治疗市场。据估计,美国占据了北美泌尿道感染治疗市场的最大份额。美国的增长估计是由于 UTI 发病率的上升、UTI 家庭诊断领域的不断发展以及提供 UTI 治疗的初创公司的存在。预计亚太地区将在未来几年以最高的复合年增长率增长。  

 

泌尿道感染治疗市场报告范围

报告属性细节
2023 年的市场规模101亿美元
2031 年市场规模130.2亿美元
全球复合年增长率(2023 - 2031)3.2%
历史数据2021-2022
预测期2023-2031
涵盖的领域按药物类别
  • 青霉素及联合用药
  • 喹诺酮类
  • 头孢菌素
  • 氨基糖苷类抗生素
  • 磺胺类药物
  • 营养补充剂
按适应症
  • 复杂性尿路感染和非复杂性尿路感染
按分销渠道
  • 医院药房
  • 妇科及泌尿科诊所
  • 零售药店和药店
  • 网上药店
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 阿尔米拉尔公司
  • 雷迪斯博士实验室有限公司
  • 艾尔建
  • 葛兰素史克公司
  • 盐野义制药株式会社
  • 诺华公司
  • 辉瑞
  • 默克公司
  • 百时美施贵宝公司
  • 再生元制药
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

泌尿道感染治疗市场新闻和最新发展

泌尿道感染治疗市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是泌尿道感染治疗市场的发展和策略列表:

  • Allecra Therapeutics 宣布美国 FDA 批准 EXBLIFEP 用于治疗 18 岁及以上患者的复杂性尿路感染,包括肾盂肾炎。作为《立即产生抗生素激励法案》(GAIN 法案)的一部分,该公司还从 FDA 获得了为期五年的市场独占权延期。美国国会颁布的 GAIN 法案通过向合格传染病产品 (QIDP) 制造商提供福利来激励新型抗感染疗法的开发。(来源:Allecra Therapeutics GmbH,通讯,2024 年)。
  • NRx Pharmaceuticals 宣布,FDA 已接受其用于治疗复杂性尿路感染的 NRX-101 的新药临床试验 (IND) 申请。IND 审批将启动一项 2 期注册研究,以研究 NRX-101 对复杂性尿路感染患者的安全性和有效性。(来源:NRx Pharmaceuticals,公司网站,2023 年)

 

泌尿道感染治疗市场报告覆盖范围和交付成果

“泌尿道感染治疗市场规模和预测(2021-2031)”报告对以下领域进行了详细的市场分析:

  • 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态,如驱动因素、限制因素和关键机遇
  • 未来主要趋势
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports